As discussed in this review, carbonic anhydrase inhibitors (CAIs) and alpha-glucosidase inhibitors (AGIs) are used therapeutically as anti-obesity and anti-glaucoma agents, respectively, as well as antidiabetic agents. The gene discussed is GAA; the disease is Obesity.